| Authors: |
Guo M; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Keane EP; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts., Baliousis M; Department of Clinical Psychology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Gudenkauf LM; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Mate-Kole MN; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Boardman AC; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts., Larizza IS; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts., Song MT; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Wolfe ED; Department of Health Services, University of Washington School of Public Health, Seattle, Washington State., Schaefer DA; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Cutler C; Harvard Medical School, Boston, Massachusetts; Division of Transplantation and Cellular Therapy, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Jim HS; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center and Division of Hematology-Oncology, University of Washington, Seattle, Washington State., El-Jawahri A; Harvard Medical School, Boston, Massachusetts; Mass General Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Amonoo HL; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: hermioni_amonoo@dfci.harvard.edu. |
